Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Robotic therapy: the tipping point.
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System.
[Current state of research on multiple sclerosis].
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
CMT4D (NDRG1 mutation): genotype-phenotype correlations.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Fingolimod and multiple sclerosis: Four cautionary tales.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Effects of magnetization transfer on T1 contrast in human brain white matter.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

Pages